Learn more

CARSGEN THERAPEUTICS LTD

Overview
  • Total Patents
    53
  • GoodIP Patent Rank
    28,537
  • Filing trend
    ⇩ 28.0%
About

CARSGEN THERAPEUTICS LTD has a total of 53 patent applications. It decreased the IP activity by 28.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are AUTOLUS LTD, CERO THERAPEUTICS INC and NANJING IASO BIOTHERAPEUTICS CO LTD.

Patent filings per year

Chart showing CARSGEN THERAPEUTICS LTDs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Wang Huamao 37
#2 Song Bo 31
#3 Li Zonghai 20
#4 Wang Peng 19
#5 Jiang Hua 12
#6 Gao Huiping 12
#7 Shi Bizhi 10
#8 Cai Xiumei 9
#9 Shi Zhimin 5
#10 Gu Jianren 4

Latest patents

Publication Filing date Title
JP2020099326A Nucleic acid for coding chimeric antigen receptor protein and t lymphocyte for expression of chimeric antigen receptor protein
US2020062843A1 Anti-cd19 humanized antibody and immune effector cell targeting cd19
CN109796532A Target combining unit and its application of fibroblast activation protein α
CN109385400A Co-express the immune effector cell of the Chimeric antigen receptor modification of PD-L1 blocking agent
CN106467573A Anti- mesothelin human antibody and the immune effector cell of targeting mesothelin
SG11201800989RA Antibody against glypican-3 and application thereof
WO2016150400A1 Immune effectorcell of targeting cldn6, and preparation method therefor and application thereof
WO2016086813A1 Gpc3 and asgpr1 double-targeted transgenic immune effector cell and use thereof
CN106519037A Chimeric receptor capable of being activated
EP3170842A1 Immunologic effector cell of targeted cld18a2, and preparation method and use thereof
WO2015197016A1 Time and space adjustable system for inhibiting pathological target cells
GB201620536D0 Nucleic acid for coding chimeric antigen receptor protein and T lymphocyte for expression of chimeric antigen receptor protein
CN107460201A Encode the nucleic acid of the Chimeric antigen receptor albumen of GPC 3 and express the T lymphocytes of the Chimeric antigen receptor albumen of GPC 3